NEW YORK--(BUSINESS WIRE)--April 12, 2006--Callisto Pharmaceuticals, Inc. (AMEX:KAL - News; FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, will discuss its drug development pipeline and key results of recent clinical and research studies involving its drug candidates to investment professionals at the Equities 55th Anniversary Conference, to be held at The Yale Club, 50 Vanderbilt Ave., New York, NY on April 21, 2006, in New York City.
